Tag Archives: Patent Law

USPTO Institutes “QUICK PATH” IDS PILOT Program

Posted on May 11, 2012 by Warren Woessner

The USPTO has announced the implementation of a pilot program, effective from May 16th until September 30th, to permit applicants to file IDS statements after payment of the issue fee in utility and reissue applications, without the need to continue … Continue reading →

Posted in USPTO Practice and Policy | Tagged , , , , , , , , , , , , | Leave a comment

In re Montgomery – “Unbounded” Inherency

Posted on May 10, 2012 by Warren Woessner

In re Montgomery, App no. 2011-1376 (Fed. Cir. May 8, 2012) (a copy is available at the end of this post), a divided panel affirmed the Board’s decision that a claim to a “new use for an old compound” was … Continue reading →

Posted in Anticipation | Tagged , , , , , , , , , , | Leave a comment

Otsuka v. Sandoz – Motivation Trumps Structure

Posted on May 9, 2012 by Warren Woessner

The recent decision of the Fed. Cir. in Otsuka v. Sandoz, App. No. 2011-1126, -1127 (Fed. Cir. May 7, 2012) continues the courts admirable work in defining obviousness post-KSR. This case revisits the standards involved in making out a prima-facie … Continue reading →

Posted in Obviousness | Tagged , , , | Leave a comment

Prometheus Q/A Results: Does Patent Eligibility Impact Biotech Research?

Posted on May 7, 2012 by Warren Woessner

A guest post from shareholder Robin Chadwick of SLW. A quick survey of folks who read this blog indicates that funding for 5 Buy Cheap Cialis Soft 0% of respondents’ R&D is affected by whether or not a project was … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , | Leave a comment